PASYLATION
Live / Registered — Registered — Section 71 accepted (as of 07 Oct 2024)
What this means for you
Registered since 18 Feb 2014. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79126686
- Registration number
- 4483086
- Mark type
- Stylized text
- Filed
- 17 Oct 2012
- Published for opposition
- 03 Dec 2013
- Registered
- 18 Feb 2014
- Attorney of record
- Anthony G. Craig
Goods and services
- Class 001 — Chemicals: [ Chemicals and biochemicals for research and laboratory purposes excluding for medical or veterinary purposes, and for industrial and scientific purposes; [ unprocessed artificial resins, unprocessed plastics; ] chemical and biological preparations for medical research and medical and scientific purposes ]
- Class 005 — Pharmaceuticals: [ Pharmaceutical and veterinary preparations and preparations for human medical purposes for use in treating growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; [ sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, nutritional supplements containing proteins, peptides, food for babies; preparations for destroying vermin; fungicides, herbicides; ] pharmaceutical and diagnostic preparations for medical [, dental and forensic ] purposes and for purposes of [ forensic medicine and ] laboratory medicine, namely, pharmaceutical and diagnostic preparations for diagnosis, prevention, treatment or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; testing reagents in kit form for medical, [ dental and forensic ] purposes and for purposes of [ forensic medicine and ] laboratory medicine, namely, medical [ and forensic ] diagnostic reagents and assays for testing of body tissues and body fluids; chemical and biotechnological preparations for medical and diagnostic purposes, namely, reagents and solvents for sample preparation, modification and manipulation of cells and for performing of marking, separation, isolation, purification, amplification and/or analytical methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes included in this class; medicaments for preventive, curative and palliative purposes for preventing, treating or curing of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; medical biomarkers, in particular for preventative, diagnostic, prognostic or predictive purposes, namely, polypeptide sequences; [ medical preparations, namely, kits for laboratory medicine in particular for preventive, diagnostic, prognostic or predictive purposes, namely, diagnostic kits consisting primarily of proteins, buffers, and reagents for use in detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; ] biomolecules for medical purposes, namely, proteins, peptides and small molecule drugs with conjugated polypeptide sequences for binding of active substances; medical preparations for analytical purposes, namely, reagents for detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; preparations for health care, namely, for diagnosis, prevention, treatment, or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases ]
- Class 042 — Scientific and technological services: Scientific and technological services and research, namely, scientific research, analysis, testing, in the fields of chemistry, genetics, biology, biotechnology and biochemistry; [ technical services, namely, computer diagnostic services in the field of DNA, RNA and protein expression, detection and analysis and respective design services, in particular in the fields of chemistry, genetics, biology, biotechnology and biochemistry; industrial analysis and research services in the field of medical, dental, forensic and scientific research; design and development of computer hardware and software; ] services of a chemical and biochemical laboratory; scientific research including conducting of scientific examinations; and preparation of scientific opinions; quality checking, namely, quality evaluation services for the medical and pharmaceutical industry; [ design and development of programs for data processing; ] consultancy for scientific, laboratory and research purposes in the field of chemistry, genetics, biology, biotechnology and biochemistry; [ scientific services of a technical measuring and test laboratory; ] technological consulting services pertaining to scientific and industrial scientific research in the fields of generation, technical processing and technical analysis of biomaterials and medically relevant data
Owner
- XL-protein GmbH, Freising, DE
- XL-protein GmbH, 85354 Freising, DE
- XL-protein GmbH, Freising, DE
Prosecution history
- 30 Oct 2025 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 08 Jun 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 07 Oct 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 07 Oct 2024 — REGISTERED-SEC.71 ACCEPTED
- 07 Oct 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Feb 2024 — TEAS SECTION 71 RECEIVED
- 18 Feb 2023 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 04 Nov 2022 — INTERNATIONAL REGISTRATION RENEWED
- 02 Jul 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 09 Sept 2021 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 29 Aug 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 13 Feb 2021 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 01 Jan 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 31 Dec 2020 — INVALIDATION PROCESSED
- 29 Dec 2020 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED